Skip to main content

Site-Specific DNA Recombinases

Recombinase systems are used to remove no longer needed selection markers when creating knock-in or allelic series models and/or to create conditional tissue- or cell-specific mutations. The two most common systems are Cre recombinase from bacteriophage P1 and FLP recombinase from yeast (Saccharomyces cerevisiae). Both Cre and FLP recombinase catalyze an irreversible, site-specific DNA recombination event between two 34-bp recognition sites, loxP and FRT, respectively. The 34-bp loxP and FRT recognition sites consist of two 13-bp inverse repeats flanking an 8-bp core sequence; the core sequences confer directionality.

Mutations are then created conditionally by expressing the appropriate recombinase in a particular tissue or during a specific time period (i.e., during embryonic development). Recombinase systems can also be used to mis-express genes spatially or temporally, for example during embryogenesis or ontogeny, when expression of the recombinase deletes stop codon sequences thus allowing transcription of a particular gene of interest. Recombinase-mediated recombination is most commonly accomplished using transgenic deletor mouse strains that express Cre/FLP in a tissue specific manner. Recombinases can also be delivered locally, i.e. blown into the lung or injected into a muscle, to modulate gene expression.

Recombinase systems are also used to delete intron-placed marker genes. Removal of the selection marker allows the targeting of yet another gene in a previously targeted ES cell clone. It has also been reported that the intronic PGK-neo marker gene, if left intact, can act as a hypomorphic allele (ref). Reduced gene expression resulted from improper RNA slicing into a cryptic acceptor site within the PGK-neo gene.

Use of a combination of both the Cre/loxP and FLPe/FRT systems in targeting vector design is highly recommended if considering a 3-loxP design. Inclusion of a combination of these elements in the targeting vector results in more straightforward and efficient deletion when creating conditional mutations and allows greater versatility in the use of the mice.

Follow Center for Genetic Medicine on